-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Primary tremor (ET)
Also known as essential tremor
A common movement disorder characterized clinically by postural or action tremor at the distal extremities, which may be accompanied by head, orofacial or voice tremors
.
Between 30% and 50% of patients with ET have a family history
.
The conventional wisdom is that ET is a benign, familial, monosymptomatic disease, but ET is currently considered to be a slow-progressing, complex disease
that may be associated with family inheritance.
Clinical features
Age of onset: It can occur at all ages, more common in middle-aged and elderly people over 40 years old, and some people think that adolescents are another peak
of onset.
Familial onset is earlier than in patients with sporadic ET, more often before the age of 20 years
.
Clinical core symptoms: 4-12Hz postural or action tremor as the main feature, mostly occur in the hands and forearms, but can also involve the head (such as neck), lower limbs, voice, etc.
, occasionally involving the tongue, face, trunk and other parts
.
Tremor can affect multiple sites at the same time
, such as the forearm and head.
Daily activities such as writing, pouring water, and eating can worsen the tremor, and most patients have reduced
symptoms after drinking.
As the course of the disease increases, the tremor frequency decreases and the amplitude increases, leading to more severe dysfunction
.
Tremor involvement may increase gradually, usually several years after upper extremity involvement, and usually the trunk and lower extremities are usually affected later
.
Clinical grading of tremor: according to the tremor grading standard proposed by the National Institutes of Health Essential Tremor Research Group in 1996 for reference:
Grade 0: no tremor;
Grade 1: mild, imperceptible tremor;
Grade 2: moderate, tremor amplitude< 2cm, non-disabled;
Grade 3: obvious, tremor amplitude of 2-4cm, partially disabled;
Grade 4: severe, tremor amplitude of more than 4cm, disability
.
Diagnostic criteria
Core diagnostic criteria:
(1) Obvious and persistent postural and/or action tremor of both hands and forearms;
(2) not accompanied by other neurological signs (except for gear phenomenon and Directed sign);
(3) There may be only head tremor, but not accompanied by dystonia
.
Supported diagnostic criteria:
(1) The course of the disease is more than 3 years;
(2) Have a positive family history;
(3) Tremor is reduced
after drinking.
Exclusion Criteria:
(1) There are factors that cause physiological hyperkinetic tremor; Enhanced physiological tremor: Tremor movements
exist in normal people's limbs, head, tongue, and trunk.
When young, this tremor is rapid and subtle, and imperceptible, and with age, the amplitude of the tremor increases and the frequency slows down, especially in certain postures
.
This physiological tremor has little effect on daily life, but may worsen into irregular rocking tremor movements
when intense fear, anxiety, rage, insomnia, heavy alcohol consumption, or taking certain medications.
(2) Are or have recently used tremor-causing drugs or are in the withdrawal period;
(3) History of neurological trauma within 3 months before the onset of disease;
(4) have a history or clinical evidence of psychiatric (psychological) tremor; Such as hysteria;
(5) Sudden onset of disease or stepwise progression and deterioration
of the condition.
differential diagnosis
Physiological tremor, psychomental tremor, Parkinson's disease tremor, cerebellar tremor, dystonia tremor, erythronucleus tremor, primary orthostatic tremor, Wilson's disease tremor, tremor caused by internal medicine system diseases (such as hyperthyroidism, hepatic encephalopathy, etc
.
).
1.
Parkinson's disease tremor: mainly resting tremor, can be combined with action tremor, hand pill-like tremor and lower limb resting tremor is a typical manifestation of
Parkinson's disease.
In addition to tremor, Parkinson's disease patients are often accompanied by bradykinosis, muscle rigidity, postural gait abnormalities, and the late stage can be accompanied by reduced joint movements, freezing phenomenon, etc
.
2.
Cerebellar tremor: mainly intentional tremor of the upper and lower limbs, often accompanied by other signs of the cerebellum, such as ataxia, abnormal rotational movements, poor distance discrimination, etc.
, and ET patients are usually not accompanied by cerebellar symptoms
.
3.
Psychotic tremor: mostly occurs when there are certain mental factors such as anxiety, nervousness, fear, compared with ET, its frequency is faster (8-12 Hz), but the amplitude is small, there are corresponding psychological characteristics, remove the symptoms of the precipitating factor can disappear
.
Treatment of ET
Treatment of ET is divided into drugs (oral drugs and botulinum toxin type A) and surgical treatment
.
The principles of drug treatment are:
(1) Mild tremor does not require treatment;
(2) Due to work or social needs, mild to moderate patients can choose to take medication half an hour before the event to intermittently reduce symptoms;
(3) moderate to severe tremor that affects daily life and work and requires drug treatment;
(4) Drug-refractory severe patients can consider surgical treatment;
(5) Patients with head or voice tremor can choose type A botulinum toxin injection treatment
.
According to the recommended levels of A, B and C of evidence-based medicine, combined with the actual situation in China, the drugs for the treatment of ET are divided into first-line, second-line and third-line drugs
.
First-line drugs: propranolol, arololol, primidone;
Second-line drugs: gabapentin, topiramate, alprazolam, atenolol, sotalol, clonazepam;
Third-line medications: clozapine, nadolol, nimodipine, botulinum toxin
type A.
Propranolol, arrolol, and primidone are the preferred initial agents for ET and can be used in combination when monotherapy is ineffective; Botulinum toxin type A multipoint intramuscular injection may be effective in patients with head or voice tremors; Surgical treatment is suitable for patients with
severe symptoms and refractory drugs.
First-line recommended medications:
1.
Propranolol:
It is a non-selective epinephrine β blocker and is a classic first-line treatment
.
(non-selective, acts on β1 and β2 receptors )
(1) Usage: Start with a small dose (10mg / time, 2 times a day), gradually increase the dose (5 mg / time) to 30-60mg / d, you can have symptom improvement, generally not more than 90mg / d; Standard tablets are taken orally 3 times a day, controlled-release tablets are taken once a day, and the drug
is taken in the morning.
(2) Efficacy: It can effectively reduce the amplitude of limb tremor by 50% (the frequency is not reduced), but the efficacy of axial tremor (such as head, voice, etc.
) is not good
.
(3) Adverse reactions: most side effects are the corresponding epinephrine β receptor blocking effect, common pulse rate reduction and blood pressure drop, but the heart rate above 60 times / min can basically be tolerated, during the medication should closely observe the heart rate and blood pressure changes, such as heart rate < 60 times / min can be considered to reduce the dose, < 55 times / min to stop the drug; Other rare side effects include fatigue, nausea, diarrhea, rash, impotence, and depression
.
(4) Unstable cardiac insufficiency, high atrioventricular block, asthma, insulin-dependent diabetes and other relative contraindications
.
2.
Primidone:
It is a commonly used antiepileptic drug
.
(1) Usage: generally start from 25mg per night, gradually increase the amount of 25mg / time, the effective dose is 50-500 mg / d, generally 250mg / d has good efficacy and good
tolerance.
To reduce the side effects of drowsiness, it is recommended to take the drug
at night before going to bed.
(2) Efficacy: The effect on hand tremor is significant, which can reduce the tremor amplitude
by 50%.
(3) Adverse reactions: In the early stage of medication, the incidence of acute side effects (including dizziness, nausea, vomiting, walking instability, drowsiness, acute toxicity, etc.
) is relatively high, and most of the adverse reactions will gradually weaken or reach tolerance
after a few days.
3.
Arololol
It has a and β-receptor blocking effect (its action ratio is roughly 1:8).
(1) Usage: The oral dose starts from 10mg, once a day, if the efficacy is insufficient, the dose can be increased to 2 times a day, 10mg / time, the maximum dose does not exceed 30mg / d
.
(2) Efficacy: It can reduce the amplitude of postural tremor and action tremor, and the efficacy is similar
to that of propranolol.
Compared with propranolol, the β-receptor blocking activity of arolol is 4~5 times, and it is not easy to pass through the blood-brain barrier, and will not produce central nervous system side effects
like propranolol.
Therefore, it may be considered in patients who cannot tolerate
propranolol.
(3) Adverse reactions: bradycardia, dizziness, hypotension, etc
.
Heart rate and blood pressure changes should be closely observed during medication, such as less than 60 times / min or obvious hypotension should be reduced or discontinued
.
Second-line recommended medication:
1.
Gabapentin:
It is a derivative of Υ-aminobutyric acid, which belongs to a new type of anti-epileptic carbuncle and anti-neuralgia drugs
.
(1) Usage: The initial dose is 300 mg/d, and the effective dose is 1200-3600 mg/d, divided
into 3 times.
(2) Efficacy: Monotherapy can relieve symptoms, the efficacy may be similar to propranolol, as an addition to other drugs can not further improve symptoms
.
(3) Adverse reactions: drowsiness, nausea, dizziness, unsteady walking, etc
.
2.
Topiramate:
It is a new type of anti-epileptic drug with the effect of
blocking sodium channels and enhancing the activity of Υ-aminobutyric acid.
(1) Usage: The initial dose is 25mg/d, slowly increased at an increasing rate of 25mg/week, orally divided into 2 times, and the conventional therapeutic dose is 100-400mg/d
.
(2) Efficacy: The efficacy is slightly inferior to the first 4 drugs, but it can improve various tremors
to a certain extent.
(3) Adverse reactions: loss of appetite, weight loss, nausea, paresthesia, cognitive impairment (especially language IQ), etc
.
3.
Alprazolam:
It is a short-acting benzodiazepine preparation
.
(1) Usage: The initial dose is 0.
6mg/d, most of which are administered 3 times a day, and the effective therapeutic dose is 0.
6-2.
4mg/d
.
(2) Efficacy: reduce the tremor amplitude by 25%-34%, which can be used in elderly patients
who cannot tolerate propranolol, arrolol and primidone.
(3) Adverse reactions: excessive sedation, fatigue, unresponsiveness, etc.
, long-term use may occur drug dependence
.
4.
Atenolol:
It is a selective beta-1 blocker
.
(1) Usage: 50~150mg/d can relieve symptoms
.
Indicated for asthmatic patients
who cannot use beta2 and non-selective receptor blockers.
(2) Efficacy: The efficacy of this class of selective β1 blockers is inferior to that of non-selective receptor blockers
.
(3) Adverse reactions: dizziness, nausea, cough, dry mouth, drowsiness, etc
.
5.
Sotalol is a non-selective β receptor blocker
.
(1) Usage: 80~240mg/d can relieve symptoms
.
(2) Efficacy: Its efficacy is second only to propranolol and arolol
in adrenergic β receptor blockers.
6.
Metoprolol (beta-1 blocker)
7.
Clonazepam:
It is a benzodiazepine preparation
.
(1) Usage: The initial dose is 0.
5 mg/d, and the effective therapeutic dose is 1-6 mg/d
.
(2) Efficacy: It can effectively reduce the amplitude
of action tremor.
(3) Adverse reactions: dizziness, unsteady walking, excessive sedation, etc.
, long-term use can occur drug dependence
.
Second-line recommended medication:
The nonselective β receptor-blocker naldolol 120 to 240 mg/day or the calcium antagonist nimodipine 120 mg/day or the nonclassical antipsychotic clozapine 25 to 75 mg/day may be effective
in improving limb tremor.
Clozapine has the side effects of granulocytopenia and arrhythmias and should only be considered if other medical treatments are ineffective, and CBC and ECG
should be monitored during use.
Compared with oral drugs, botulinum toxin type A has advantages in the treatment of head and voice tremors, and can also be used for the treatment
of limb tremors.
A single dose of 40-400 IU improves tremor in the head; Choosing multiple injections of 50-100 IU of ulnar and radial wrist extensor muscles can reduce the tremor amplitude of the upper limbs, finger weakness and limb stiffness are the most common side effects; Soft palate injections of 0.
6 IU can treat voice tremor, but side effects
such as hoarseness and dysphagia may occur.
Botulinum toxin type A is a symptomatic treatment measure for refractory tremor, usually the effect of 1 injection lasts 3~6 months, and repeated injections are required to maintain the effect
.
Surgical treatment:
ET surgical treatments mainly include stereotactic thalamic destruction and deep thalamic stimulation (DBS), both of which can improve tremor
.
Bilateral thalamic destruction has a high probability of dysarthria and cognitive dysfunction, and increases intraoperative and postoperative risks, so it is not recommended for clinical treatment
.
DBS has the characteristics of low trauma, reversibility and controllability, and is the preferred surgical treatment for patients with drug-refractory severe ET.
Side effects include paresthesia, local pain, dysarthria, and imbalance, which can be corrected
in part by changing the stimulation parameters.